Morgan Stanley Upgrades Gilead Sciences, Says It Will Maintain 75% Market Share

Morgan Stanley upgraded Gilead Sciences, Inc. (NASDAQ: GILD) from Equal-weight to Overweight on Monday and raised its price target ...